Analyst Price Target is $0.62
▲ +138.92% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Indiva in the last 3 months. The average price target is $0.62, with a high forecast of $0.62 and a low forecast of $0.62. The average price target represents a 138.92% upside from the last price of $0.26.
Current Consensus is
The current consensus among 1 contributing investment analysts is to buy stock in Indiva.
Indiva Limited operates as a licensed producer of cannabis products in Canada. It creates premium pre-rolls, flower, capsules, and edible products, as well as provides production and manufacturing services to peer entities. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Ruby Cannabis Sugar, Sapphire Cannabis Salt, Artisan Batch, and other powered by INDIVA products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.